NEXVET BIOPHARMA PUB LTD CO - ORD SHS (NVET)

CUSIP: G6503X109

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / ORD SHS
Total 13F shares
5,909,577
Share change
-92,063
Total reported value
$21,510,000
Price per share
$3.64
Number of holders
18
Value change
-$334,938
Number of buys
9
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP G6503X109?
CUSIP G6503X109 identifies NVET - NEXVET BIOPHARMA PUB LTD CO - ORD SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEXVET BIOPHARMA PUB LTD CO - ORD SHS (NVET) as of Q3 2015

As of 30 Sep 2015, NEXVET BIOPHARMA PUB LTD CO - ORD SHS (NVET) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,909,577 shares. The largest 10 holders included FARALLON CAPITAL MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, ADAGE CAPITAL PARTNERS GP LLC, Foresite Capital Management II, LLC, JENNISON ASSOCIATES LLC, BANK OF AMERICA CORP /DE/, NORGES BANK, CQS Cayman LP, COWEN GROUP, INC., and KCG Holdings, Inc.. This page lists 18 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.